Stock Symbol:   

Stoxline Mobile
Home  |  Stock Charts  |  Showcases  |  Stock Ranks  |  Options  |  ETFs  |  Educations

Celsion Corp (CLSN)

2.86   0.15 (5.54%) 06-04 16:00
Open: 2.69 Pre. Close: 2.71
High: 3 Low: 2.68
Volume: 1,366,577 Market Cap: 84M
Celsion Corp is a fully-integrated oncology drug development company. The Company is engaged in developing a portfolio of cancer treatments, including directed chemotherapies, immunotherapies and RNA- or DNA-based therapies.

Stock Price Prediction

Update at 5:00pm EST
If tomorrow: Open lower Open higher
High: 3.001 - 3.02 3.02 - 3.037
Low: 2.641 - 2.66 2.66 - 2.679
Close: 2.829 - 2.859 2.859 - 2.888

Technical analysis

as of: 2020-06-04 4:29:50 PM
Stoxline posted a SELL today, same as yesterday. Downward movement continues.
Target: Six months: 4.25     One year: 4.97
Support: Support1: 2.12    Support2: 1.18
Resistance: Resistance1: 3.64    Resistance2: 4.25
Pivot: 2.39
Moving Average: MA(5): 2.86     MA(20): 2.11
MA(100): 1.38     MA(250): 1.55
MACD: MACD(12,26): 0.45     Signal(9): 0.40
Stochastic oscillator: %K(14,3): 64.60     %D(3): 66.71
RSI: RSI(14): 74.45
52-week: High: 3.64  Low: 0.69  Change(%): 52.9
Average Vol(K): 3-Month: 116829  10-Days: 537456

Price, moving averages and Bollinger Bands

Price and moving averages has closed above its Short term moving average. Short term moving average is currently above mid-term; AND above long term moving averages. From the relationship between price and moving averages; we can see that: This stock is BULLISH in short-term; and BULLISH in mid-long term.
CLSN has closed below upper band by 32.7%. Bollinger Bands are 392.3% wider than normal. The large width of the bands suggest high volatility as compared to CLSN's normal range. The bands have been in this wide range for 10 bars. This is a sign that the current trend might continue.

Headline News

Tue, 19 May 2020
Celsion: Big Gains Possible In July - Seeking Alpha

Wed, 27 May 2020
Thinking about buying stock in Biocept, Celsion Corp, Tilray, Altimmune, or Ford? - PRNewswire

Wed, 20 May 2020
Is Celsion Corporation (CLSN) a Stock to Watch This Week? - InvestorsObserver

Fri, 15 May 2020
Celsion Corporation Reports First Quarter 2020 Financial Results and Provides Business Update - GlobeNewswire

Thu, 04 Jun 2020
Market Analysts see Celsion Corporation [CLSN] gaining to $7. Time to buy? - The DBT News

Thu, 21 May 2020
Celsion Corporation [CLSN] gain 0.58% so far this year. What now? - The DBT News

Financial Analysis

Growth measures the growth of both a company's revenue and net income. it tells investors how fast a company is growing.
Profitability measures a company’s ability to generate earnings as compared to its expenses and other relevant costs.
Solvency measures a company's ability to meet its long-term debts. Acceptable solvency ratios will vary from industry to industry.
Efficiency measures the strength of a company's return on invested capital. It can identify business that are better managed or not.
Click here to get more fundamental analysis.
Free Technical Analysis Charts

Stock Basics & Statistics

Exchange:  NASDAQ
Sector:  Healthcare
Industry:  Biotechnology
Shares Out. (M) 29
Shares Float (M) 27
% Held by Insiders 1.29
% Held by Institutions 15.61
Shares Short (K) 104
Shares Short P. Month (K) 67

Stock Financials

EPS -0.831
EPS Est This Year -3.500
EPS Est Next Year -1.170
Book Value (p.s.) 0.550
Profit Margin
Operating Margin -4094.18
Return on Assets (ttm) -30.3
Return on Equity (ttm) -103.9
Qtrly Rev. Growth
Gross Profit (p.s.) -0.430
Sales Per Share 0.017
EBITDA (p.s.) -0.675
Qtrly Earnings Growth
Operating Cash Flow (M) -20
Levered Free Cash Flow (M) -14

Stock Valuations

PE Ratio -3.44
PEG Ratio
Price to Book value 5.20
Price to Sales 167.37
Price to Cash Flow -4.25

Stock Dividends

Forward Dividend
Dividend Yield
Dividend Pay Date Invalid DateTime.
Ex-Dividend Date Invalid DateTime.
7 Binary Options
Your Ad Here
Stock Chart
Stoxline Lite
Stoxline Pro
Option Calculator
(c) 2006-2020 | Contact us           
Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the web site, a user agrees not to redistribute the information found therein.